6/16/20
Dynavax, the manufacturer of a next generation HepB vaccine, Heplisav-B, (HepB-CpG) is hosting additional informative webinars this month. Heplisav-B is the impressive 2 dose hepatitis B vaccine for patients 18+. Dr. Offit shares information on this vaccine in his brief video.
As many as 2.2 million people in the US are infected with hepatitis B, and cases are on the rise. While hepatitis B is a vaccine preventable disease, only 25% of adults over the age of 19 are fully vaccinated. Hepatitis B is the primary cause of liver cancer, which is the 2nd leading cause of cancer deaths in the world- it’s time to reconsider vaccination options.
Join the hosted webinar to discuss hepatitis B and innovations in vaccination options.
This educational presentation will include also a live Q & A session.
Please choose from the options below:
Hepatitis B Overview and Innovations in Immunization
Presented by: John Youhanna, PharmD, RPh, Regional Medical Director, Dynavax Technologies
June 18th
10am – 11am PST / 11am – 12pm MST / 12pm – 1pm CST / 1pm – 2pm EST
June 23rd
11am – 12pm PST / 12pm – 1pm MST / 1pm – 2pm CST / 2pm – 3pm EST
June 25th
9am – 10am PST / 10am – 11am MST / 11am – 12pm CST / 12pm – 1pm EST
Heplisav-B is available for MPPG members at a discount through www.vaccineshoppe.com.